http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1346151-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1ee62deaac38b56b38648135a89eac
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1985-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce5436a96b05962045b67b1b7e1983b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00f27b779c04120eca147a951f4bccd
publicationDate 1987-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1346151-A1
titleOfInvention Method of treatment of open-angle glaucoma
abstract The invention relates to medicine, namely to ophthalmology, and can be used to improve the flow of intraocular fluid through the drainage of the eye with the normalization of intraocular pressure. To simplify the method of treatment and prevention of intraoperative and postoperative complications, transconjunctival implants affect the sclera for 8-11 s in the projection of the anterior chamber angle drainage structures. so 4 ;: a
priorityDate 1985-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411

Total number of triples: 19.